Quality Improvement Initiative in Hypertrophic Cardiomyopathy (QIIC)

The BMS Quality Improvement Initiative in Hypertrophic Cardiomyopathy (QIIC) aims to support institutions and healthcare professionals involved in the diagnosis and care of patients with obstructive hypertrophic cardiomyopathy (oHCM) to improve the care gaps in making center-specific changes.

The BMS QIIC is open to all not-for-profit health care organizations in Canada. Healthcare professionals employed by or holding a position in a hospital, and actively involved in the delivery of health care to oHCM patients are eligible to apply on behalf of their Institution. The list of eligible professionals includes, but is not limited to:

• Physicians
• Nurses and all nursing-affiliated personnel
• Hospital pharmacists
• Allied health professionals
• Other hospital-based professionals that participate in or who have an interest in improving the diagnosis and delivery of care to oHCM patients

Projects requesting up to 50,000ドル will be considered. Please refer to the Applicant Guide for additional details. Projects must have the potential to transfer knowledge and experience gained, to other disease state, healthcare teams or hospitals.

Applicants should download the QIIC Application Form and return the completed form to QIICardio@bms.com by May 31, 2025. Applications received after the deadline will not be reviewed.

Applicants will be notified of decisions by July 15th, 2025.